Arbutus Biopharma Corporation · NASDAQ:ABUS

Whitefort Capital Master Fund, LP reported a 8.00% stake in Arbutus Biopharma Corporation (Schedule 13D/A)

Event Apr 24, 2026 · Filed Apr 28, 2026

Whitefort Capital Master Fund, LP reported a 8.00% stake in Arbutus Biopharma Corporation, 15,794,261 shares, with active intent on Apr 24, 2026. Filed Apr 28, 2026 (Schedule 13D/A).

Stake
8.00%
Shares
15,794,261
Intent
Active
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Whitefort Capital Master Fund, LP8.00%15,794,261
Whitefort Capital GP, LLC8.00%15,794,261
Whitefort Capital Management, LP8.00%15,794,261
Whitefort Capital Management GP, LLC8.00%15,794,261
David Salanic8.00%15,794,261
Joseph Kaplan8.00%15,794,261

Source

View original at SEC

Related